ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $554,000 | +1.7% | 112,859 | +9.4% | 0.00% | – |
| Q2 2021 | $545,000 | +598.7% | 103,159 | +537.5% | 0.00% | – |
| Q1 2021 | $78,000 | +23.8% | 16,183 | +11.0% | 0.00% | – |
| Q4 2020 | $63,000 | +5.0% | 14,583 | 0.0% | 0.00% | – |
| Q3 2020 | $60,000 | -53.1% | 14,583 | -70.8% | 0.00% | – |
| Q2 2020 | $128,000 | -90.0% | 49,883 | -88.7% | 0.00% | – |
| Q1 2020 | $1,279,000 | -19.6% | 442,509 | +5.5% | 0.00% | – |
| Q4 2019 | $1,590,000 | -25.6% | 419,504 | +0.5% | 0.00% | – |
| Q3 2019 | $2,136,000 | -15.5% | 417,524 | +2.4% | 0.00% | – |
| Q2 2019 | $2,529,000 | -8.7% | 407,911 | +4.7% | 0.00% | – |
| Q1 2019 | $2,771,000 | -17.5% | 389,740 | -0.9% | 0.00% | – |
| Q4 2018 | $3,359,000 | -90.9% | 393,293 | -78.6% | 0.00% | -100.0% |
| Q3 2018 | $36,771,000 | -35.0% | 1,836,892 | -16.2% | 0.00% | -40.0% |
| Q2 2018 | $56,612,000 | -15.5% | 2,191,792 | -21.8% | 0.01% | -16.7% |
| Q1 2018 | $66,996,000 | +45.0% | 2,803,107 | +105.6% | 0.01% | +50.0% |
| Q4 2017 | $46,209,000 | +738.0% | 1,363,501 | +423.5% | 0.00% | – |
| Q3 2017 | $5,514,000 | +10.5% | 260,474 | -8.7% | 0.00% | – |
| Q2 2017 | $4,990,000 | +8.9% | 285,359 | +9.1% | 0.00% | – |
| Q1 2017 | $4,582,000 | +5.2% | 261,651 | +1.5% | 0.00% | – |
| Q4 2016 | $4,356,000 | +9.5% | 257,685 | +6.3% | 0.00% | – |
| Q3 2016 | $3,978,000 | +16.9% | 242,469 | +7.9% | 0.00% | – |
| Q2 2016 | $3,403,000 | +38.0% | 224,715 | +31.6% | 0.00% | – |
| Q1 2016 | $2,466,000 | -45.5% | 170,759 | +6.9% | 0.00% | – |
| Q4 2015 | $4,524,000 | +95.1% | 159,757 | +15.4% | 0.00% | – |
| Q3 2015 | $2,319,000 | -1.2% | 138,487 | +54.8% | 0.00% | – |
| Q2 2015 | $2,347,000 | +343.7% | 89,440 | +195.1% | 0.00% | – |
| Q1 2015 | $529,000 | +29.0% | 30,307 | +27.9% | 0.00% | – |
| Q4 2014 | $410,000 | -3.3% | 23,698 | +4.2% | 0.00% | – |
| Q3 2014 | $424,000 | – | 22,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
| Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
| Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
| Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
| DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
| Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
| EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
| DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |